Novartis Says Pharma Needs More Than Drugs; Investors May Be Persuaded
Executive Summary
Pharmaceutical companies should diversify their business portfolios to maximize growth, Novartis Head of Corporate Mergers & Acquisitions Nayan Gregory Parekh said Sept. 27
You may also be interested in...
Kindler’s Honeymoon Over? Analysts Press Pfizer Execs On Series Of Stumbles
The sheen of Pfizer's new management team - including CEO Jeffrey Kindler - may be beginning to wear off, based on analyst comments during Pfizer's April 20 first-quarter earnings call
Kindler’s Honeymoon Over? Analysts Press Pfizer Execs On Series Of Stumbles
The sheen of Pfizer's new management team - including CEO Jeffrey Kindler - may be beginning to wear off, based on analyst comments during Pfizer's April 20 first-quarter earnings call
Novartis’ “Captainship” Program Produces More Hypertension Market Share
Nearly a year after introducing its "category captainship" strategy to enhance its leadership position in the market, Novartis is reporting its most successful quarter in the hypertension market